If knockdown experiments revealed specific repression effects during differentiation, it is plausible that KDM4A overexpression may help optimize laboratory methodologies for generating pancreatic β-cells, potentially advancing regenerative therapies for diabetes mellitus. Here, KDM4A is linked to diabetes mellitus.